TUEs! TUEs for everyone!
Ultimate Fighting Championship (UFC) light heavyweight veteran Gian Villante recently failed a drug text administered by United States Anti-Doping Agency (USADA), but will face no punishment after scoring a retroactive therapeutic use exemption (TUE) for his inhaler.
Villante flunked an out-of-competition drug test administered on Jan. 18, but disclosed the use of his Breo Ellipta inhaler, which subsequently returned positive for the banned substance vilanterol.
From the official release:
“Upon a thorough investigation into the circumstances surrounding Villante’s use of vilanterol, which included the retroactive TUE application process, USADA determined that the athlete had an unequivocally diagnosed acute medical condition for which the use of vilanterol is consistent with the standard of care. Further, it was determined that the short-term use of the Breo Ellipta inhaler was within the manufacturer’s therapeutic recommendation and was intended to return the athlete to a normal state of health without providing a performance-enhancing benefit. Finally, other permitted therapeutic alternatives were not successful at controlling the athlete’s condition.”
I guess it’s okay to inhale after all.
With that little mess out of the way, Villante can move on to fight Mauricio Rua at the upcoming UFC Fight Night 106: “Belfort vs. Gastelum” mixed martial arts (MMA) event on Sat., March 11, 2017, inside Centro de Formacao Olimpica do Nordeste in Fortaleza, Ceara, Brazil.
For much more on that FOX Sports 1 fight card click here.
Source:: mma mania